Founder Directory
Built by Keitoto
Founders3
Known for these resultsRole0%Role is parsed from founder titles in yc.db. Known for 0% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company0%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 0% of these rows have at least one match.School67%School is matched from bios, case-sensitive for acronyms. 67% of these rows have at least one match.
- Burak YILMAZFounder · Kernal BiologicsS20Healthcare · Boston
- Jeff OzdemirFounder · Kernal BiologicsS20Healthcare · Boston
- Yusuf Erkul@yusuf_erkulFounder · Kernal BiologicsS20Healthcare · Boston
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Burak YILMAZKernal BiologicsFounderSummer 2020HealthcareBoston, United States20—Jeff OzdemirKernal BiologicsFounderSummer 2020HealthcareBoston, United States20—Yusuf ErkulKernal BiologicsFounderSummer 2020HealthcareBoston, United States20https://x.com/yusuf_erkul
Showing 1–3 of 3 founders
Yusuf Erkul
Founder·Kernal Biologics
PRIMARY INFO
RoleFounder· not in title
Team size20
BatchSummer 2020
LocationBoston, United States
Company statusActive
StageEarly
BIO
I'm co-founder and CEO of Kernal Biologics, a Boston-based biotech startup developing next-generation messenger RNA immunotherapy. Backed by Hummingbird, Amgen, Lilly, NVIDIA, HBM, NASA, and Boeing, Kernal Bio raised more than $30M. Early in my career, I worked at Merck&Co. on the discovery and development of various oncology drugs, including ZEJULA®, which got FDA approval for ovarian cancer. I hold an executive MBA from MIT Sloan, an M.D. from Hacettepe Univ. and a B.S. in Biology from MIT.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsMBAMD
DisciplineBusinessKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
Kernal BiologicsKernal is creating mRNA 2.0 therapies that work in specific cells
